These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32410546)

  • 21. Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation.
    Maruzzelli L; Parr AJ; Miraglia R; Tuzzolino F; Luca A
    Acad Radiol; 2014 Apr; 21(4):507-13. PubMed ID: 24594420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations.
    Jawahar A; Gonzalez B; Balasubramanian N; Adams W; Goldberg A
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1389-1396. PubMed ID: 28957871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Changes in Liver Fat Content in Asymptomatic Adults: Hepatic Attenuation on Unenhanced CT as an Imaging Biomarker for Steatosis.
    Hahn L; Reeder SB; Muñoz del Rio A; Pickhardt PJ
    AJR Am J Roentgenol; 2015 Dec; 205(6):1167-72. PubMed ID: 26587921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography.
    Rockall AG; Sohaib SA; Evans D; Kaltsas G; Isidori AM; Monson JP; Besser GM; Grossman AB; Reznek RH
    Eur J Endocrinol; 2003 Dec; 149(6):543-8. PubMed ID: 14640995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters.
    Yoo J; Joo I; Jeon SK; Park J; Yoon SH
    Eur Radiol; 2024 Sep; 34(9):6205-6213. PubMed ID: 38393403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic fat quantification in dual-layer computed tomography using a three-material decomposition algorithm.
    Demondion E; Ernst O; Louvet A; Robert B; Kafri G; Langzam E; Vermersch M
    Eur Radiol; 2024 Jun; 34(6):3708-3718. PubMed ID: 37955671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol.
    Jang S; Lee CH; Choi KM; Lee J; Choi JW; Kim KA; Park CM
    World J Gastroenterol; 2011 Jul; 17(28):3335-41. PubMed ID: 21876622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.
    Pickhardt PJ; Graffy PM; Reeder SB; Hernando D; Li K
    AJR Am J Roentgenol; 2018 Sep; 211(3):W151-W157. PubMed ID: 30016142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher frequency of hepatic steatosis at CT among COVID-19-positive patients.
    Medeiros AK; Barbisan CC; Cruz IR; de Araújo EM; Libânio BB; Albuquerque KS; Torres US
    Abdom Radiol (NY); 2020 Sep; 45(9):2748-2754. PubMed ID: 32683613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-energy non-contrast hepatic steatosis criteria applied to virtual non-contrast images: is it still highly specific and positively predictive?
    Haji-Momenian S; Parkinson W; Khati N; Brindle K; Earls J; Zeman RK
    Clin Radiol; 2018 Jun; 73(6):594.e7-594.e15. PubMed ID: 29526439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity, Hepatic Steatosis, and Their Impact on Fat Infiltration of the Trunk Musculature Using Unenhanced Computed Tomography.
    Sebro R
    J Comput Assist Tomogr; 2017; 41(2):298-301. PubMed ID: 28230568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment.
    Graffy PM; Sandfort V; Summers RM; Pickhardt PJ
    Radiology; 2019 Nov; 293(2):334-342. PubMed ID: 31526254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy.
    Nishino M; Hayakawa K; Nakamura Y; Morimoto T; Mukaihara S
    AJR Am J Roentgenol; 2003 Jan; 180(1):129-34. PubMed ID: 12490491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of hepatic steatosis severity and coronary artery disease characteristics assessed by coronary CT angiography.
    Tomizawa N; Inoh S; Nojo T; Nakamura S
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():73-82. PubMed ID: 26831056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic Steatosis: CT-Based Prevalence in Adults in China and the United States and Associations With Age, Sex, and Body Mass Index.
    Guo Z; Blake GM; Graffy PM; Sandfort V; Summers RM; Li K; Xu S; Chen Y; Zhou J; Shao J; Jiang Y; Qu H; Li B; Cheng X; Pickhardt PJ
    AJR Am J Roentgenol; 2022 May; 218(5):846-857. PubMed ID: 34817193
    [No Abstract]   [Full Text] [Related]  

  • 36. Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI.
    Min JH; Kang TW; Kim YY; Cha DI; Kim YK; Kim SH; Sinn DH; Ha SY; Kim K
    Eur Radiol; 2021 May; 31(5):3315-3325. PubMed ID: 33159576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral adipose tissue area is an independent risk factor for hepatic steatosis.
    Park BJ; Kim YJ; Kim DH; Kim W; Jung YJ; Yoon JH; Kim CY; Cho YM; Kim SH; Lee KB; Jang JJ; Lee HS
    J Gastroenterol Hepatol; 2008 Jun; 23(6):900-7. PubMed ID: 17995942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of blood flow and xenon solubility coefficient in the human liver by xenon-enhanced computed tomography.
    Sase S; Takahashi H; Shigefuku R; Ikeda H; Kobayashi M; Matsumoto N; Suzuki M
    Med Phys; 2012 Dec; 39(12):7553-9. PubMed ID: 23231303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications.
    Pickhardt PJ; Hahn L; Muñoz del Rio A; Park SH; Reeder SB; Said A
    AJR Am J Roentgenol; 2014 Apr; 202(4):752-8. PubMed ID: 24660702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patients.
    Shores NJ; Link K; Fernandez A; Geisinger KR; Davis M; Nguyen T; Sawyer J; Rudel L
    Dig Dis Sci; 2011 Jul; 56(7):2145-51. PubMed ID: 21318585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.